Indy Hematology Review 2027 Agenda

2027 scientific program with presentation sessions, expert panels, product theaters, and an evening town hall.
Saturday, March 13th, 2027

Morning Program

Session Chair: Ruemu E. Birhiray, MD

Time Event/Topic
6:00 - 10:00 AM Registration
6:45 - 7:25 AM Breakfast Product Theater
7:30 - 8:00 AM The Next Chapter in Hematology: Breakthroughs Reshaping Care in 2027
Ruemu E. Birhiray, MD
8:00 - 8:20 AM Getting the First Move Right: New Frontiers in Newly Diagnosed AML and MDS
Guillermo Garcia-Manero, MD
8:20 - 8:40 AM When Disease Returns: Rewriting the Playbook for Relapsed AML and MDS
Rami Komrokji, MD
8:40 - 8:55 AM At the Crossroads of Evidence and Action: Acute Leukemias and MDS Panel
8:55 - 9:05 AM Coffee Break and Exhibit Hall
9:05 - 9:25 AM Starting Strong in Myeloma: Building the Best First Treatment
Kenneth Anderson, MD
9:25 - 9:45 AM The Next Best Move: Navigating Relapse in Multiple Myeloma
Saad Usmani, MD
9:45 - 10:05 AM Reading the Biology, Guiding the Therapy: Waldenström Macroglobulinemia in 2027
Steven Treon, MD, PhD
10:05 - 10:25 AM Mobilizing Immunity Against Myeloma: Choosing the Right Therapy at the Right Time
Joselle Cook, MBBS
10:25 - 10:45 AM When the Case Defies the Algorithm: Plasma Cell Neoplasms Panel
10:45 - 11:10 AM Steven Coutré Memorial Lecture in Hematology Innovation:Challenging the Incurable: The Past, Present, and Future of Therapeutic Innovation in Leukemia
Hagop M. Kantarjian, MD
11:10 - 11:15 AM Steven Coutré Memorial Lecture: Questions and Answers
Hagop M. Kantarjian, MD
11:15 - 11:25 AM Coffee Break and Exhibit Hall

Session Chair through 1:20 PM: Ruemu E. Birhiray, MD

Afternoon Session Chair: Michael Wiemann, MD, FACP

Time Event/Topic
11:25 - 11:45 AM Restoring the Balance: New Possibilities in Aplastic Anemia and Complementopathies
Neal Young, MD
11:45 AM - 12:05 PM Between Bleeding and Clotting: Navigating the Critical Decisions in Classical Hematology
Craig Kessler, MD
12:05 - 12:25 PM Rare Diseases, Rising Possibilities: Advances in Myeloid and Mast Cell Neoplasms
Naveen Pemmaraju, MD
12:25 - 12:35 PM Uncommon Disorders, Consequential Decisions: Classical and Rare Hematology Panel
12:35 - 12:40 PM Coffee Break and Exhibit Hall
12:40 - 1:20 PM Luncheon Product Theaters
1:20 - 1:25 PM Coffee Break and Exhibit Hall
1:25 - 1:30 PM Named Sponsor Induction
1:30 - 2:10 PM T. Howard Lee Keynote Lecture — Seeing Tomorrow, Treating Today: The Evolving Art of Prognostication in Myeloid Neoplasms
Ayalew Tefferi, MD
2:10 - 2:15 PM What Will Change Practice Next? Distinguished Lecturer Panel
2:15 - 2:35 PM Sickle Cell Disease 2027: From Molecular Innovation to Clinical Transformation — What's Next?
Swee Lay Thein, MBBS, DSc
2:35 - 2:55 PM Beyond Disease Control: Choosing Initial Therapy and Pursuing Treatment-Free Remission in CML
Richard Larson, MD
2:55 - 3:15 PM The First Choice Matters: Matching Frontline CLL Therapy to the Patient
Nitin Jain, MD
3:15 - 3:35 PM After the First Line: Finding the Next Best Path in Relapsed CLL
Jennifer Woyach, MD
3:35 - 3:40 PM Choosing the Path, Planning the Future: Chronic Leukemias Panel
3:40 - 3:45 PM Coffee Break and Exhibit Hall
3:45 - 4:10 PM Meeting Aggressive Disease with Smarter Therapy: Advances in B and T Cell Lymphomas
John Leonard, MD
4:10 - 4:30 PM Primum Curare: Advancing Cure While Reducing Treatment Burden in Hodgkin Lymphoma
Stephen Ansell, MD, PhD
4:30 - 4:50 PM The Long Game in Indolent Lymphoma: When to Treat, What to Choose, What Comes Next
Nancy Bartlett, MD
4:50 - 5:00 PM Beyond the Trial Results: Making Lymphoma Advances Work for Patients
5:00 - 5:20 PM ALL at a Turning Point: Bringing Targeted and Immune Therapies into Focus
Richard Stone, MD
5:20 - 5:40 PM Redirecting T Cells, Redefining Possibilities: Antibody Therapies for Lymphoid Malignancies
Tycel Phillips, MD
5:40 - 6:00 PM Living Therapies, Lasting Ambitions: The Next Era of Cellular Therapy for Lymphoid Malignancies
Matthew Lunning, DO
6:00 - 6:20 PM Beyond the Myeloma Lens: Recognizing and Treating Amyloidosis and Other Plasma Cell Disorders
Morie Gertz, MD
6:20 - 6:40 PM The Window of Opportunity: When to Refer for Transplantation and Cellular Therapy
Richard Childs, MD
6:40 - 6:45 PM From Possibility to Practice: Lymphoid Malignancies and Cellular Therapies Panel
6:45 - 7:00 PM Hors d'Oeuvres
7:00 - 8:00 PM Hematology at the Crossroads: The Decisions We Face, the Future We Shape — 2027 Townhall
Ruemu E. Birhiray, MD

Chair and Moderator: Ruemu E. Birhiray, MD

Townhall Faculty

  • Morie Gertz, MD

  • Jennifer Woyach, MD

  • Guillermo Garcia-Manero, MD

  • John Leonard, MD

  • Saad Usmani, MD

  • Ayalew Tefferi, MD

  • Richard Childs, MD

  • Naveen Pemmaraju, MD